Biblio
.
Chimeric Antigen Receptor-modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model. J Immunother. 2018.
Correction to "Red-Emissive Carbon Quantum Dots for Nuclear Drug Delivery in Cancer Stem Cells". J Phys Chem Lett. 2020:4345.
. Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA. Cell Discov. 2016;2:15052.
. Genome-Wide Analysis of Human MicroRNA Stability. Biomed Res Int. 2013;2013:368975.
. Leveraging CD16 fusion receptors to remodel the immune response for enhancing anti-tumor immunotherapy in iPSC-derived NK cells. J Hematol Oncol. 2023;16(1):62.
. Red-Emissive Carbon Quantum Dots for Nuclear Drug Delivery in Cancer Stem Cells. J Phys Chem Lett. 2020:1357-1363.
.